UK - GlaxoSmithKline and Unilever have both revealed massive pensions deficits in their latest financial results.
GSK revealed the FRS17 deficit on its final salary schemes, last valued at £4.3bn, rose to £1.3bn last year – up from £457m in 2001. GSK injected £320m into its schemes in the last quarter of 20...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders